Shares of Novavax Inc. NVAX shed 3.23% to $6.00 Thursday, on what proved to be an all-around dismal trading session for the ...

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Novavax (NVAX – Research Report) today and set a price target of ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Novavax (NVAX) closed the most recent trading day at $6.39, moving -0.31% from the previous trading session. This move lagged the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

Trump warned of coming pharma tariffs following an historic roller-coaster day for stocks in which the 90-day pause sparked a nearly 8% gain for the Dow Jones Industrial Average, which finished the ...

Healthcare stocks ended a volatile Wall Street week on a positive note. Explore top movers, Novartis' $23B U.S.